Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Ma TM, et al. Among authors: pepin a. Radiother Oncol. 2022 Jan;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. Radiother Oncol. 2022. PMID: 34774650
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).
Pepin A, Aghdam N, Shah S, Kataria S, Tsou H Jr, Datta S, Danner M, Ayoob M, Yung T, Lei S, Gurka M, Collins BT, Krishnan P, Suy S, Hankins R, Lynch JH, Collins SP. Pepin A, et al. Front Oncol. 2020 May 5;10:555. doi: 10.3389/fonc.2020.00555. eCollection 2020. Front Oncol. 2020. PMID: 32432033 Free PMC article.
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer.
Aghdam N, Pepin AN, Creswell M, Hsieh K, Smith C, Drescher N, Danner M, Ayoob M, Yung T, Lei S, Kumar D, Collins BT, Lischalk JW, Krishnan P, Suy S, Lynch J, Bandi G, Hankins RA, Collins SP. Aghdam N, et al. Front Oncol. 2020 Oct 29;10:551491. doi: 10.3389/fonc.2020.551491. eCollection 2020. Front Oncol. 2020. PMID: 33251131 Free PMC article.
Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer.
Aghdam N, Repka MC, McGunigal M, Pepin A, Paydar I, Rudra S, Paudel N, Pernia Marin M, Suy S, Collins SP, Barnes W, Collins BT. Aghdam N, et al. Among authors: pepin a. Front Oncol. 2020 Dec 10;10:572564. doi: 10.3389/fonc.2020.572564. eCollection 2020. Front Oncol. 2020. PMID: 33425723 Free PMC article.
Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal-Prostate Interface and Spare the Rectum: A Case Report.
Conroy D, Becht K, Forsthoefel M, Pepin AN, Lei S, Rashid A, Collins BT, Lischalk JW, Suy S, Aghdam N, Hankins RA, Collins SP. Conroy D, et al. Among authors: pepin an. Front Oncol. 2021 Jan 7;10:607698. doi: 10.3389/fonc.2020.607698. eCollection 2020. Front Oncol. 2021. PMID: 33489918 Free PMC article.
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy.
Carrasquilla M, Creswell ML, Pepin AN, Wang E, Forsthoefel M, McGunigal M, Bullock E, Lei S, Collins BT, Lischalk JW, Esposito G, Aghdam N, Kumar D, Suy S, Leger P, Hankins RA, Dawson NA, Collins SP. Carrasquilla M, et al. Among authors: pepin an. Front Oncol. 2021 Jan 18;10:606260. doi: 10.3389/fonc.2020.606260. eCollection 2020. Front Oncol. 2021. PMID: 33537236 Free PMC article. Review.
88 results